Bang Chen has registered 15 drugs in China, 9 drugs have been approved for production, 3 drugs have completed clinical research, 4 drugs have been approved for clinical research, and 7 drugs are being evaluated by the National Drug Evaluation Center.
Bang Chen has rich experience in channel management, product management and prescription drug promotion. Bang Chen has more than 450 regional distributors in China, covering 65% of cities in China and more than 2,000 medium-sized hospitals. It has outstanding pharmaceutical marketing strength in all fields of medicine.
Our team
We have a young and active team:
Bang Chen's main researchers have 8- 12 years' experience in drug research and development and registration, and have completed all kinds of domestic drug research and development and registration applications, and are excellent domestic drug research and development and registration teams.
Bang Chen's marketing team has over 100 million yuan experience in promoting OTC and prescription drugs, with an average age of about 30. It is an iron army that is always full of vitality and dares to fight hard.
Bang Chen's team has excellent educational background, and most of them graduated from famous universities: China Europe Business School, London Business School, Otago University, Peking University, Fudan University School of Pharmacy, West China University of Medical Sciences, Shenyang Pharmaceutical University, etc.
Bang Chen's senior managers have rich practical experience and advanced management concepts, and once served as the president of a large multinational company in China, which will surely lead the team to the road of collective success.
Team Bang Chen is working together with Qi Xin's enthusiasm to push the company to a new level.
Scientific research center
Our scientific research aim is: people-oriented, committed to the improvement of human health, and strive for the development of medicine and human physical and mental health. At present, the vassal States adopt the way of combining production, learning and research, aiming at production transformation and focusing on the treatment of frequently-occurring diseases, and develop new drugs and generic drugs. A series of product combinations have been developed in the fields of digestive system and nervous system.
The company's R&D center undertook two special funds for science and technology in Shanghai, and obtained various new drug certificates and more than 10 production approvals. As of April, 2009, R&D Center has obtained the Shanghai High-tech Achievements Transformation Project 1 and applied for national invention patents 13, including 2 patents. In 2007, the company was rated as a high-tech enterprise in Shanghai. R&D Center insists on continuously introducing products that are in line with international standards and leading in China in the fields of digestion, psychiatry and other treatments. Bang Chen has also introduced many excellent products in other therapeutic fields. With the continuous strengthening of R&D center's scientific research strength and the continuous improvement of technical equipment, we will introduce more and better new drugs and make contributions to human health!
Commercial shopping center
Bang Chen has launched a series of products through market planning, investigation and analysis, product positioning, 4P plan, market training and other means, which has rapidly expanded its market share.
Marketing:
Marketing ability is the most important ability besides drug research and development and registration in Bang Chen. The company has set up a marketing department with more than 10 people to provide market support for products marketed nationwide and formulate accurate market strategies; Marketers have a profound background in the pharmaceutical industry, and many of them have master's and MBA degrees.
Distribution:
Distribution is the main sales strategy and organizational form of vassal States at present.
Through a well-organized national distribution network, Bang Chen quickly distributed its products to more than 300 cities and entered more than 2,000 hospitals.
Bang Chen is the first 1 pharmaceutical company in China. It adopts the world-leading CRM system of salesforce Company in the United States to manage the distributor network and end-customer resources distributed all over the country.
The vassals are:
More than 450 qualified dealers after screening;
More than 8,000 potential distributors interested in Bang Chen products;
There are more than 2,000 medium-sized hospitals in various places (accounting for 33% of the national medium-sized hospitals).
Direct selling:
The company will soon set up a sales team for terminal hospitals to sell new drugs developed by R&D center that need clinical education.
Career opportunities
Bang Chen Company is a small company with a broad platform. There are not many rules and regulations in vassal countries, and fast-growing companies can give candidates a big and broad career development platform.
When the company develops rapidly, it is the time when the company employs people, and candidates have the opportunity to directly or gradually enter the top management of the company; We hope to find honest, capable, potential, passionate and ambitious managers to create a career with us;
The company continues to invest in R&D and marketing network to increase the company's core competitiveness. At the same time, the company also continuously invests in management, invites outstanding candidates, and improves the company's management ability.
Corporate culture is a young entrepreneurial culture, and we hope that thoughtful and capable candidates can create an excellent management platform and "win" ability.
The rapidly developing princes shared the fruits of success with the employees of the company and offered passionate salaries.
If you are interested, please apply directly on the website or send your resume to hr-recruiting@chenpon.com. Please name your resume "Name-Application Position".
Legal Representative: Du Dizheng
Date of establishment: 1027267200
Registered capital: 50 million yuan.
Location: Shanghai.
Unified social credit code: 91310000741195036u.
Business status: survival (in business, in business, in registration)
Industry: scientific research and technical services
Company type: joint stock limited company (unlisted, invested or controlled by natural persons)
English name: Shanghai Bang Chen Pharmaceutical Technology Co., Ltd.
Number of employees: 100-499.
Address: Zone A, 4th floor, Building 80, Lane Zu Chongzhi Road 1505, China (Shanghai) Pilot Free Trade Zone.
Business scope: research and development of biomedical products and inspection technologies, related technical consultation and technical services, market information consultation and investigation (social investigation, social research, public opinion survey and opinion poll are not allowed), sales of chemical raw materials (except dangerous chemicals, monitored chemicals, civil explosives and precursor chemicals) and packaging materials.
Projects that must be approved according to law can only carry out business activities after being approved by the relevant departments.